The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: omeprazole     Quarter: 2016Q3

Total Records: 1,129     Number of Pages: 57

DRUGNAME PT EventCount
OMEPRAZOLE. Ophthalmoplegia 2
OMEPRAZOLE. Oral mucosal erythema 2
OMEPRAZOLE. Oropharyngeal discomfort 2
OMEPRAZOLE. Pancreatic enlargement 2
OMEPRAZOLE. Parkinson's disease 2
OMEPRAZOLE. Peripheral arterial occlusive disease 2
OMEPRAZOLE. Petit mal epilepsy 2
OMEPRAZOLE. Pneumonia aspiration 2
OMEPRAZOLE. Precancerous cells present 2
OMEPRAZOLE. Presyncope 2
OMEPRAZOLE. Product odour abnormal 2
OMEPRAZOLE. Pruritus generalised 2
OMEPRAZOLE. Pulmonary function test decreased 2
OMEPRAZOLE. Pulse absent 2
OMEPRAZOLE. Rash pustular 2
OMEPRAZOLE. Red blood cell count decreased 2
OMEPRAZOLE. Renal disorder 2
OMEPRAZOLE. Renal tubular disorder 2
OMEPRAZOLE. Respiratory distress 2
OMEPRAZOLE. Respiratory moniliasis 2

Total Records: 1,129     Number of Pages: 57